If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
380.00    30.00 (8.57%)
Bid:
370.00
Ask:
390.00
Spread: 20.00 (5.405%)
Market Cap: £36.31m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Debt refinancing

Today 07:00

RNS Number : 6910K
Cropper(James) PLC
02 July 2026
 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION PURSUANT TO ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

2 July 2026

 

James Cropper plc

("James Cropper", the "Company" or the "Group")

 

Debt refinancing

 

James Cropper plc (AIM: CRPR), the Advanced Materials and Paper & Packaging group, is pleased to announce the completion of a refinancing of its debt facilities. This refinancing provides the Group with a more flexible funding platform to support delivery of its medium-term strategic priorities.

 

The new arrangements improve the Group's cash flow and balance sheet flexibility through access to a new invoice discounting facility of up to £15m committed for at least three years, which provides flexible working capital funding to enable more efficient management of the Group's liquidity.

 

As part of the refinancing, the Group will make a part-repayment of £7.1m on its existing UK bank loan, funded from the Group's cash resources and the new invoice discounting facility, with the remaining balance repayable in reduced quarterly instalments through to March 2030.

 

In addition, the maturity of the Group's US bank loan has been extended by 12 months, with the final repayment of $3.2m deferred to December 2027, improving liquidity headroom during this period.

 

Alongside the debt refinancing, the Group has agreed to make a one-off contribution into its defined benefit pension schemes of £0.6m, with the previously agreed contribution schedule reduced by £0.35m in aggregate across the period to September 2027. In addition, the Group has agreed to bring forward the next triennial actuarial valuation of the pension schemes by 12 months to March 2027. 

 

Andrew Goody, Chief Financial Officer, said: "This refinancing builds on the significant progress we have made in strengthening the Group's balance sheet through improved operational performance and continued focus on cash and working capital management, with net debt at 28 March 2026 less than 1x adjusted EBITDA.

 

"The refinancing materially improves our liquidity and financial flexibility. By improving access to committed working capital funding and extending the maturity profile of our debt, the new arrangements provide greater headroom to support both operational requirements and strategic growth initiatives.

 

"Importantly, the refinancing allows us to deploy capital more efficiently, which we expect will allow the Group to reduce cash financing costs. I am grateful to our lending partners for their continued support and to HSBC Invoice Finance for helping deliver this important enhancement to our funding structure."

 

-END-

Enquiries

 

James Cropper plc

David Stirling, CEO

Andrew Goody, CFO

 

Tel: +44 (0)1539 722 002

Shore Capital - Nominated Adviser and Broker

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

 

Tel: +44 (0)207 408 4090

IFC Advisory - Financial PR

Graham Herring, Tim Metcalfe, Zach Cohen

Tel: +44 (0) 203 934 6630

james.cropper@investor-focus.co.uk

 

 

About James Cropper

 

James Cropper plc is globally recognised for its specialist capabilities in the design and manufacture of advanced materials and paper products. Operating through two principal businesses - Advanced Materials and Paper & Packaging - and built upon 180 years of innovation, the Group serves a diverse range of customers with high-performance solutions tailored to specialised applications.

 

The Advanced Materials business develops cutting-edge nonwoven materials and electrochemical coatings for sectors including aerospace, clean energy, and defence. The Paper & Packaging business offers premium creative papers and bespoke moulded fibre packaging together with leading recycled-fibre capabilities and products, supporting the transition to a circular economy.

 

Headquartered in Burneside (UK), with additional manufacturing sites in Crewe (UK), Launceston (UK), and Schenectady (USA), James Cropper leverages deep expertise in material science and longstanding partnerships with industry-leading businesses and brands to develop bespoke solutions that meet complex technical and aesthetic specifications.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFRDFILIIR
Date   Source Headline
20th Dec 20073:20 pmRNSHolding(s) in Company
30th Nov 20079:10 amRNSHolding(s) in Company
27th Nov 20072:45 pmRNSHolding(s) in Company
20th Nov 20077:30 amRNSInterim Results
5th Nov 20077:00 amRNSNotice of Results
4th Oct 20073:20 pmRNSHolding(s) in Company
10th Sep 20072:21 pmRNSHolding(s) in Company
31st Aug 20078:00 amRNSCancellation - Cropper(James)
20th Aug 20074:10 pmRNSSch 1 Update -James Cropper
17th Aug 20074:36 pmRNSHolding(s) in Company
1st Aug 20072:46 pmRNSSchedule 1 -James Cropper plc
1st Aug 200712:10 pmRNSAGM and EGM Results
1st Aug 200710:48 amRNSAGM and IMS
31st Jul 200711:34 amRNSHolding(s) in Company
20th Jul 20072:54 pmRNSAnnual Information Update
20th Jul 20072:43 pmRNSSale of Pension Scheme Shares
10th Jul 20074:22 pmRNSChange of Shareholding
9th Jul 20074:59 pmRNSCircular re-transfer to AIM
29th Jun 20075:06 pmRNSHolding(s) in Company
19th Jun 20077:30 amRNSFinal Results
6th Jun 200710:49 amRNSTotal Voting Rights
24th May 20079:43 amRNSTrading Update
18th May 20077:00 amRNSNotice of Results
1st May 200711:47 amRNSChange of Adviser
21st Mar 20076:13 pmRNSHolding(s) in Company
15th Mar 20074:11 pmRNSHolding(s) in Company
7th Feb 20071:07 pmRNSIssue of Equity - Replacement
2nd Feb 20078:35 amRNSBlock Listing
1st Feb 20077:30 amRNSTrading Statement
11th Dec 20064:34 pmRNSVoting Rights and Capital
21st Nov 20067:30 amRNSInterim Results
6th Nov 20069:49 amRNSNotice of Results
25th Oct 200610:13 amRNSMain Board Appointment
18th Jul 20063:21 pmRNSAnnual Information Update
4th Jul 200610:16 amRNSHolding(s) in Company
20th Jun 20067:30 amRNSFinal Results
19th May 20067:00 amRNSNotice of Results
4th May 20069:13 amRNSHolding(s) in Company
7th Mar 20069:55 amRNSDirector/PDMR Shareholding
21st Dec 20055:27 pmRNSHolding(s) in Company
20th Dec 20059:20 amRNSDirector/PDMR Shareholding
6th Dec 20058:25 amRNSHolding(s) in Company
22nd Nov 20057:30 amRNSInterim Results
7th Nov 20057:00 amRNSNotice of Results
10th Aug 20059:18 amRNSAnnual Information Update
8th Aug 200512:10 pmRNSHolding(s) in Company
5th Aug 20054:07 pmRNSHolding(s) in Company
5th Aug 20054:04 pmRNSHolding(s) in Company
3rd Aug 20051:01 pmRNSAGM Statement
21st Jul 20051:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.